Arcadia Biosciences, Inc. Closes Underwriters’ Option to Purchase Additional Shares

DAVIS, Calif.–(BUSINESS WIRE)–Arcadia Biosciences, Inc. (NASDAQ: RKDA) announced that it closed the sale of an additional 328,306 shares of its common stock at the public offering price of $8.00 per share pursuant to the exercise by the underwriters of their option to purchase additional shares of common stock in connection with Arcadia’s recently completed initial public offering. The exercise of this option brings the total number of shares of common stock sold by Arcadia in its initial pub

Print Friendly, PDF & Email

Share This

Share this post with your friends!